Stock 688300 NOVORAY CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Novoray Corporation

Equities

688300

CNE100003PN0

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
48.1 CNY +1.16% Intraday chart for Novoray Corporation -10.48% -9.16%
03/06 Novary CFO Resigns MT
25/04 Novoray Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.35 times its estimated earnings per share for the ongoing year.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Commodity Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
NOVORAY CORPORATION Stock Novoray Corporation
-9.16% 122.95Cr -
AIR LIQUIDE Stock Air Liquide
+0.73% 9.96TCr
A-
SABIC Stock SABIC
-11.98% 5.88TCr
A-
PT CHANDRA ASRI PACIFIC TBK Stock PT Chandra Asri Pacific Tbk
+75.71% 4.88TCr
B
WANHUA CHEMICAL GROUP CO., LTD. Stock Wanhua Chemical Group Co., Ltd.
+5.26% 3.49TCr
B
WESTLAKE CORPORATION Stock Westlake Corporation
+3.47% 1.86TCr
B-
NINGXIA BAOFENG ENERGY GROUP CO., LTD. Stock Ningxia Baofeng Energy Group Co., Ltd.
+17.33% 1.74TCr
C+
HENGLI PETROCHEMICAL CO.,LTD. Stock Hengli Petrochemical Co.,Ltd.
+5.92% 1.35TCr
B-
RONGSHENG PETROCHEMICAL CO., LTD. Stock Rongsheng Petrochemical Co., Ltd.
-6.67% 1.27TCr
B
NAN YA PLASTICS CORPORATION Stock Nan Ya Plastics Corporation
-25.86% 1.2TCr
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 688300 Stock
  4. Ratings Novoray Corporation